{
    "trace": [
        {
            "role": "user",
            "content": [
                {
                    "type": "text",
                    "text": "Which of the following methods should be used to account for research and development costs with no alternative future use?\n\nA. Charging all costs to expense when incurred.\nB. Capitalizing all costs when incurred.\nC. Capitalizing costs specified by management and charging all other costs to expense.\nD. Accumulating all costs in a separate component of stockholders' equity until the existence of future benefits can be determined.\n"
                }
            ]
        },
        {
            "role": "assistant",
            "content": [
                {
                    "type": "text",
                    "text": "A. Charging all costs to expense when incurred."
                }
            ]
        },
        {
            "role": "user",
            "content": [
                {
                    "type": "text",
                    "text": "Now, output the final answer and nothing else:"
                }
            ]
        },
        {
            "role": "assistant",
            "content": [
                {
                    "type": "text",
                    "text": "A"
                }
            ]
        }
    ],
    "final_answer": "A",
    "label": "A"
}